StockComparison Logo
vs

CME vs GSK

Comparison between CME Group Inc - Class A (CME, Company) and GSK Plc (GSK, Company).

CME is from the Financial Services sector, while GSK is from the Healthcare sector.

5-Year PerformanceCME has outperformed GSK, delivering a return of +11.3% compared to +5.4%

CME vs GSK - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
CME
$104B
GSK
$103B
Max Drawdown
CME
77.97%
Winner
GSK
64.03%
Sharpe Ratio
CME
0.04
Winner
GSK
1.27
5Y Beta
Winner
CME
-0.11
GSK
0.25
Industry
CME
Financial Data & Stock Exchanges
GSK
Drug Manufacturers - General
P/E Ratio
CME
25.64
Winner
GSK
11.89
Forward P/E
CME
23.47
Winner
GSK
9.85
PEG Ratio
CME
1.36
Winner
GSK
0.10
Dividend Yield
CME
1.76%
Winner
GSK
3.57%
5Y Dividends CAGR
Winner
CME
13.49%
GSK
-8.44%
5Y EPS CAGR
Winner
CME
14.51%
GSK
4.65%
Debt to Equity
Winner
CME
0.00%
GSK
106.74%
Free Cash Flow Yield
CME
4.18%
Winner
GSK
8.17%
P/S Ratio
CME
15.49
Winner
GSK
3.10
P/B Ratio
Winner
CME
3.90
GSK
4.19

CME vs GSK - Historical Returns

Returns include dividend reinvestment.

1M
Winner
CME
-7.12%
GSK
-12.15%
3M
Winner
CME
-6.23%
GSK
-13.89%
6M
CME
+4.67%
Winner
GSK
+9.93%
1Y
CME
+3.60%
Winner
GSK
+42.14%
5Y(CAGR)
Winner
CME
+11.30%
GSK
+5.35%
10Y(CAGR)
Winner
CME
+15.99%
GSK
+4.24%
Max(CAGR)
Winner
CME
+19.77%
GSK
+3.02%

CME vs GSK - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearCMEGSK
2026+6.83%+2.38%
2025+19.58%+50.62%
2024+16.19%-6.27%
2023+30.69%+9.25%
2022-21.87%-32.73%
2021+31.45%+23.62%
2020-6.86%-17.52%
2019+11.17%+30.36%
2018+33.27%+9.29%
2017+33.42%-3.80%
2016+36.85%+1.52%
2015+8.30%+0.48%
2014+19.08%-14.73%
2013+61.87%+26.97%
2012+10.43%-0.75%
2011-21.38%+22.51%
2010-4.57%-3.72%
2009+60.84%+20.27%
2008-68.28%-21.93%
2007+31.94%-2.77%
2006+41.19%+6.93%
2005+69.85%+9.96%
2004+216.18%+5.08%
2003+67.26%+25.04%
2002+1.77%-22.83%
2001N/A-9.58%
2000N/A+5.67%
1999N/A-5.78%

CME vs GSK Drawdown Comparison

The maximum drawdown for CME was -77.49%, occurring on Nov 20, 2008. Recovery took 2170 trading sessions.

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The current CME drawdown is -11.75%. The current GSK drawdown is -16.95%.

RankCMEGSK
#1-77.49%
Dec 21, 2007 - Aug 5, 2016
-50.11%
Apr 13, 2022 - Jan 6, 2026
#2-37.34%
Mar 4, 2020 - May 14, 2021
-49.64%
Apr 20, 2007 - Apr 18, 2012
#3-31.74%
Mar 21, 2022 - Oct 16, 2024
-45.23%
Apr 25, 2000 - Nov 11, 2005
#4-25.44%
Dec 31, 2004 - Jun 2, 2005
-32.56%
Jan 17, 2020 - Dec 10, 2021
#5-20.44%
Jul 1, 2004 - Sep 21, 2004
-27.97%
Mar 4, 2014 - Sep 3, 2019
#6-17.07%
Jul 23, 2003 - Jan 16, 2004
-26.98%
Nov 5, 1999 - Apr 11, 2000
#7-16.36%
Jan 13, 2003 - Apr 22, 2003
-16.98%
Feb 18, 2026 - May 5, 2026
#8-15.69%
Jan 24, 2007 - Aug 8, 2007
-14.45%
Jan 18, 2022 - Apr 7, 2022
#9-15.42%
Nov 16, 2018 - May 30, 2019
-10.52%
May 16, 2006 - Feb 13, 2007
#10-14.69%
Jun 16, 2021 - Oct 22, 2021
-10.48%
Oct 4, 2012 - Mar 22, 2013
#11-13.92%
Aug 2, 2005 - Sep 16, 2005
-8.45%
May 28, 2013 - Nov 1, 2013
#12-13.60%
Jul 5, 2006 - Oct 9, 2006
-8.43%
Apr 11, 2000 - Apr 25, 2000
#13-13.39%
Apr 21, 2006 - Jul 5, 2006
-8.16%
Nov 11, 2005 - Mar 8, 2006
#14-12.48%
Aug 8, 2007 - Oct 1, 2007
-7.54%
Feb 14, 2007 - Apr 16, 2007
#15-12.46%
Nov 25, 2005 - Jan 24, 2006
-7.37%
Jan 21, 2014 - Feb 13, 2014

Correlation

Correlation between CME and GSK is 0.81 which considered as a strong positive correlation - the stocks tend to move together.

0.81
-101

Dividend Comparison (2000 - 2026)

CME vs GSK dividend yield comparison.

YearCMEGSK
20262.65%0.96%
20251.83%3.42%
20244.48%4.60%
20234.58%3.75%
20225.05%5.47%
20213.00%4.99%
20203.24%5.59%
20192.74%4.35%
20182.42%5.65%
20174.20%5.83%
20164.90%6.86%
20155.41%5.93%
20144.38%6.20%
20135.61%4.51%
20127.29%5.70%
20112.30%4.83%
20101.43%5.10%
20091.37%4.39%
20084.61%5.74%
20070.50%4.09%
20060.49%3.29%
20050.50%3.03%
20040.45%3.38%
20030.87%2.77%
20020.00%3.10%
20010.00%1.54%
20000.00%4.57%

Select Stocks to Compare